New venture capital firm off to blazingly fast start

September 9, 2010
Back to TopCommentsE-mailPrintBookmark and Share

Ron Meeusen lands on his feet a lot, and now he’s doing it again in an industry in which he has virtually no experience.

A scientist by training, Meeusen was the point person for Dow AgroSciences’ foray into genetically engineered crops, and then he helped BioCrossroads figure out where the state had the best opportunities to invest in agribusiness.

He left BioCrossroads in 2005 to co-found a venture capital firm focused on food and agriculture. Originally called IN Partners LLC, the firm recently renamed itself Cultivian Ventures.

The sun is shining on him again.

With partner Andy Ziolkowski, who brought venture experience to the partnership, Meeusen closed the fund with $34 million in late 2008—just weeks after the collapse of Lehman Brothers and the onset of the financial crisis.

The 20 investors in Cultivian include traditional institutional investors; two Midwestern Farm Bureaus or their associated insurance arms; Indiana and one other Midwestern state; and a number of individuals who made bundles in food and ag.

The firm couldn’t have come into the market at a better time. Venture funds were hoarding cash for their portfolio companies, drying up the flow of capital to new investments. Not only was Cultivian one of just a handful of venture firms in North America devoted to food and ag, but it also had money burning a hole in its pocket.

Cultivian has made five investments and anticipates making a couple more before the end of the year. In the first four deals, Cultivian put out $9 million and attracted $45 million in follow-on investment from other venture firms.

About half of the 500 deals Cultivian have screened originated within its target “heartland” footprint of Minnesota to Texas and from Colorado to mid-Pennsylvania. The firm initially planned to take advantage of the plethora of research coming out of land grant institutions like Purdue University, and still does.

But only two of the five investments have been in the footprint. AquaSpy Inc., which develops high-tech moisture sensors for the irrigation industry, is headquartered in Indianapolis, and the other investment, genomics firm Divergence, is in St. Louis.

In Massachusetts, Environmental Operating Solutions makes carbon to purify water, and Harvest Automation develops greenhouse robots. San Diego-based Allylix develops terpene for flavor, fragrances and other uses.

Meeusen thinks Cultivian will accumulate more investments closer to home, but he also suspects the coasts, where the remaining three investments are located, are churning out more early stage companies due to their plentiful serial entrepreneurs.

Cultivian’s entry into the market at a time when other firms were backpedaling could set it up for huge profits. Four of the investments are later-stage, C round, deals that could bring paybacks for investors within a couple of years.

Cultivian is on track to commit its entire $34 million as early as the first quarter of 2012, about two years earlier than the five-year window demanded by investors.

So, you guessed it, another fund already is being discussed.

What does Meeusen think about all the success? He’s happy, to be sure.


Post a comment to this blog

We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
You are legally responsible for what you post and your anonymity is not guaranteed.
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
  1. Only half a million TV Viewers? And thats an increase? I knew Indycar was struggling but I didn't know it was that bad. Hell, if NASCAR hits 5 Million viewers everyone starts freaking out saying its going down hill. It has a long way to before Indycar even hits NASCAR's bad days.

  2. IU has been talking that line for years with no real progress even with the last Dean, Dr. Brater. Why will an outsider, Dr. Hess, make a difference? With no proof of additional resources (cash in the bank), and a concrete plan to move an academic model that has been outdated for decades with a faculty complacent with tenure and inertia, I can count on IU to remain the same during the tenure of Dr. Hess. One ought to look to Purdue and Notre Dame for change and innovation. It is just too bad that both of those schools do not have their own medical school. Competition might wake up IU. My guess is, that even with those additions to our State, IU will remain in its own little world squandering our State's tax dollars. Why would any donor want to contribute to IU with its track record? What is its strategy to deal with the physician shortage for our State? New leadership will not be enough for us to expect any change.

  3. How do you think the Bridges got approved? I spent a couple days researching PAC's and individual contributions to some city council members during that time. My printouts were inches thick on the two I concentrated on. Finally gave up. Was disgusted with all the donations, and who they were from. Would have taken me days and days to compile a complete list. Tried to give it to the Star reporter, but he thought it was all just fine. (and apparently he was treated well himself) He ended up being laid off or fired though. And then of course, there was land donated to the dad's club, or city, as a partial payoff. All done in the shining example of "charity." No, none of these contributions are a coincidence.

  4. I agree what kind of help or if any will be there for Dr. Ley's patients. I was a patient myself.

  5. What about the hundreds of patients who sought this doctor for the right reasons, to quit drugs. what option do these patients now have, experience horrible withdrawl or return to heroin?? those are the choices. what about the children of these former addicts who's parent(s) WILL not b able to maintain their job, for @ least 2 weeks.. There needs to b an emergency clinic opened for these patients.